ArrowMark Colorado Holdings’s Endologix Inc ELGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-3,250,469
| Closed | -$2.61M | – | 354 |
|
|
2020
Q2 | $2.61M | Sell |
3,250,469
-115,852
| -3% | -$97.9K | 0.03% | 219 |
|
|
2020
Q1 | $2.33M | Hold |
3,366,321
| – | – | 0.03% | 212 |
|
|
2019
Q4 | $5.32M | Buy |
3,366,321
+94,327
| +3% | +$264K | 0.05% | 203 |
|
|
2019
Q3 | $13M | Sell |
3,271,994
-41,258
| -1% | -$240K | 0.13% | 136 |
|
|
2019
Q2 | $24M | Buy |
3,313,252
+2,275,583
| +219% | +$15.5M | 0.23% | 101 |
|
|
2019
Q1 | $6.86M | Buy |
1,037,669
+6
| +0% | +$40 | 0.06% | 193 |
|
|
2018
Q4 | $7.43M | Buy |
1,037,663
+10,048
| +1% | +$112K | 0.08% | 200 |
|
|
2018
Q3 | $19.6M | Buy |
1,027,615
+36,245
| +4% | +$1.29M | 0.16% | 123 |
|
|
2018
Q2 | $56.1M | Buy |
991,370
+2,901
| +0.3% | +$147K | 0.52% | 72 |
|
|
2018
Q1 | $41.8M | Sell |
988,469
-542
| -0.1% | -$23.3K | 0.42% | 86 |
|
|
2017
Q4 | $52.9M | Buy |
989,011
+104,399
| +12% | +$5.51M | 0.54% | 67 |
|
|
2017
Q3 | $39.5M | Buy |
884,612
+120,698
| +16% | +$5.5M | 0.45% | 80 |
|
|
2017
Q2 | $37.1M | Buy |
763,914
+51,947
| +7% | +$3.06M | 0.46% | 80 |
|
|
2017
Q1 | $51.5M | Buy |
711,967
+62,802
| +10% | +$4.15M | 0.7% | 54 |
|
|
2016
Q4 | $37.1M | Buy |
649,165
+103,598
| +19% | +$9.49M | 0.59% | 55 |
|
|
2016
Q3 | $69.8M | Buy |
545,567
+76,963
| +16% | +$9.85M | 1.27% | 22 |
|
|
2016
Q2 | $58.4M | Sell |
468,604
-10,955
| -2% | -$1.26M | 1.18% | 26 |
|
|
2016
Q1 | $40.1M | Buy |
479,559
+126,080
| +36% | +$10.4M | 0.89% | 42 |
|
|
2015
Q4 | $35M | Buy |
353,479
+64,524
| +22% | +$6.92M | 0.96% | 27 |
|
|
2015
Q3 | $35.4M | Sell |
288,955
-57,523
| -17% | -$7.81M | 0.97% | 32 |
|
|
2015
Q2 | $53.1M | Buy |
346,478
+31,450
| +10% | +$5.19M | 1.3% | 21 |
|
|
2015
Q1 | $53.8M | Buy |
315,028
+29,607
| +10% | +$4.49M | 1.39% | 15 |
|
|
2014
Q4 | $43.6M | Buy |
285,421
+18,461
| +7% | +$2.3M | 1.12% | 24 |
|
|
2014
Q3 | $28.3M | Buy |
266,960
+15,505
| +6% | +$2.16M | 0.78% | 43 |
|
|
2014
Q2 | $38.2M | Buy |
251,455
+118,482
| +89% | +$15.8M | 1.09% | 19 |
|
|
2014
Q1 | $17.1M | Buy |
132,973
+4,369
| +3% | +$679K | 0.56% | 68 |
|
|
2013
Q4 | $22.4M | Sell |
128,604
-16,211
| -11% | -$2.79M | 0.7% | 49 |
|
|
2013
Q3 | $23.4M | Buy |
144,815
+139,415
| +2,582% | +$22M | 0.77% | 46 |
|
|
2013
Q2 | $717K | Buy |
+5,400
| New | +$762K | 0.19% | 73 |
|
Other funds holding ELGX
ArrowMark Colorado Holdings's ELGX Position: Q3 2020 in Review
ArrowMark Colorado Holdings sold out of Endologix Inc (ELGX) in Q3 2020, closing a stake of 3,250,469 shares — an estimated $2.61M sold.
ArrowMark Colorado Holdings first reported a position in ELGX in Q2 2013 and held it in 29 quarters. The position peaked at $69.8M in Q3 2016. 6 funds tracked by Wall St. Rank hold ELGX as of Q3 2020.
- ArrowMark Colorado Holdings reported no remaining Endologix Inc position as of Q3 2020 after selling out during the quarter.
- ArrowMark Colorado Holdings sold 3,250,469 Endologix Inc shares in Q3 2020, an estimated $2.61M.
- ArrowMark Colorado Holdings first reported a position in Endologix Inc in Q2 2013 and held it in 29 quarters.
- ArrowMark Colorado Holdings's Endologix Inc position peaked at $69.8M in Q3 2016.
- 6 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2020.
Based on ArrowMark Colorado Holdings's 13F filing for Q3 2020, filed 16 Nov 2020.